SIRT1 and metabolic disease: The activation of the NAMPT/NAD + /SIRT1 signaling pathway has been shown to optimize bile acid composition and decrease the production of proinflammatory cytokines, thereby ameliorating metabolic disorders in MASH model animals [123,153].